Mubasher: Omani National Pharmaceutical Industries’ (NPMI) audited financial results showed an increase in profits during the fourth quarter of 2016 by 9.9%, compared to Q4-15 results.
According to the financial results, NPMI’s profits in Q4-16 amounted to OMR 305,640 ($790,760), versus OMR 278,100 ($719,510) on a yearly basis.
Annually, NPMI’s net profits after taxes were up by 24.82% to OMR 1.32 million in 2016, versus OMR 1.05 million in 2015, according to a filing to the Muscat Securities Market (MSM).
NPMI’s total sales increased by 24.61% to OMR 13.22 million last year from OMR 10.61 million in 2015, according to a statement.
The Omani company’s profits surged by 30.17% in the first nine months of 2016 to OMR 1.01 million, compared to OMR 775,510 in the same period in 2015.
